FDA Inspection 1252841 — Shanghai Desano Bio-Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shanghai Desano Bio-Pharmaceutical Co., Ltd. on October 18, 2024 in Shanghai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 18, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shanghai (China)